Search
for
Sort by
Research 631–660 of 1000+
- 5α-Reduced glucocorticoids: a story of natural selection
- Androgens and Antiandrogens
- Associations between transition‐specific stress experience, nocturnal decline in ambulatory blood pressure, and C‐reactive protein levels among transgender men
- Prevalence of CYP21 mutations and IRS1 variant among women with polycystic ovary syndrome and adrenal androgen excess
- Role of insulin resistance and diet in acne
- Polycystic Ovarian Syndrome: Long-Term Health Consequences
- The Efficacy of 24-Month Metformin for Improving Menses, Hormones, and Metabolic Profiles in Polycystic Ovary Syndrome
- Polycystic ovary syndrome: A review for dermatologists
- Serum lipocalin-2 as an insulin resistance marker in patients with polycystic ovary syndrome
- Women's midlife health Reframing menopause
- Obesity and the Polycystic Ovary Syndrome
- The rationale for physiological testosterone replacement in women
- Lifestyle and Physiological Factors Associated with Facial Wrinkling in Men and Women
- The metabolic syndrome- associated small G protein ARL15 plays a role in adipocyte differentiation and adiponectin secretion
- Relationships Between Biochemical Markers of Hyperandrogenism and Metabolic Parameters in Women with Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis
- Polycystic Ovary Syndrome: A Common Reproductive and Metabolic Disorder Necessitating Early Recognition and Treatment
- Pharmacologic Treatment of Polycystic Ovary Syndrome
- Decreased lipin 1β expression in visceral adipose tissue is associated with insulin resistance in polycystic ovary syndrome
- Impact of Treatment with Rosiglitazone or Metformin on Biomarkers for Insulin Resistance and Metabolic Syndrome in Patients with Polycystic Ovary Syndrome
- Selenium and Polycystic Ovary Syndrome; Current Knowledge and Future Directions: A Systematic Review
- Post-finasteride syndrome
- Association between Insulin Resistance and Cardiovascular Risk Factors in Polycystic Ovary Syndrome Patients
- Increased risk of fractures in patients with polycystic ovary syndrome: a nationwide population-based retrospective cohort study
- Gynecologic and andrologic dermatology and the metabolic syndrome
- Reversal of Alopecia Universalis by Tofacitinib: A Case Report
- Clinical review 74: Dermatological manifestations of endocrine disorders.
- Bone Mineral Density is Unaltered in Women with Polycystic Ovary Syndrome
- Oligomenorrhoea in Exercising Women
- Hyperandrogenism in Adolescent Girls
- Novel Systematics of Nomenclature and Classification of Female Functional Androgenization (Including Polycystic Ovary Syndrome and Non-Classic Congenital Adrenal Hyperplasia)